{"id":"W1984096754","doi":"10.1124/jpet.102.046268","title":"N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2 H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: II. In Vivo Characterization in Rat Models of Inflammatory and Neuropathic Pain","year":2003,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":261,"is_retracted":false,"has_abstract":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Capsaicin; Hyperalgesia; Capsazepine; Chemistry; Antagonist; Nociception; Pharmacology; Neuropathic pain; Allodynia; Sciatic nerve; TRPV1; Receptor antagonist; Analgesic; Neurogenic inflammation; Endocrinology; Internal medicine; Receptor; Medicine; Transient receptor potential channel; Substance P; Biochemistry; Neuropeptide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009826646,0.0002549552,0.0005321547,0.0002621334,0.00007645695,0.00001209991,0.00006194693,0.0001185137,0.00002764803],"category_scores_gemma":[0.00001576953,0.0001873968,0.00005053665,0.0001907116,0.0001812125,0.0002609181,0.00002737286,0.0003362727,2.416011e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001453458,"about_ca_system_score_gemma":0.0001232475,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005164512,"about_ca_topic_score_gemma":0.000002769184,"domain_scores_codex":[0.9982867,0.0005270532,0.0005353942,0.000221061,0.0001896594,0.0002401875],"domain_scores_gemma":[0.9993165,0.00008498829,0.0003396521,0.00007645343,0.00008021323,0.0001021539],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003602299,0.001274758,0.01019782,0.00007838075,0.0002374596,0.0001561278,0.002108585,0.00007557934,0.9816634,0.00006203192,0.000003038665,0.0005405259],"study_design_scores_gemma":[0.009979218,0.004286821,0.002012956,0.0002555194,0.0001642221,0.0003353246,0.0004886005,0.004229202,0.9778193,0.00003902888,0.0002079429,0.000181861],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966124,0.001964639,0.0004249801,0.0001859574,0.000180527,0.0005933125,0.000006924298,0.000007728167,0.00002351806],"genre_scores_gemma":[0.9971867,0.001027274,0.0005559772,0.001101318,0.00004146553,0.00002940928,0.000003530681,0.00003138744,0.00002297038],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008184866,"threshold_uncertainty_score":0.7641819,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01660227110757358,"score_gpt":0.2691521557036838,"score_spread":0.2525498845961102,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}